17,261 trials
Diabetes Mellitus, Type 2
Primary: Time to Minimum Endogenous Glucose Production (EGP) - Meal Challenge — 75.0; 75.0; 125.0; 60 Minutes
Type 2 Diabetes Mellitus
Primary: Annual Rate of Change in FEV1 From Baseline to End of Study — -0.048 Liters per year
Infertility
Primary: Clinical Pregnancy — 71 participants
Diabetes Mellitus: Type 1
Primary: Bioequivalence of Two 15 U Cartridges (TI Inhalation Powder A) and One 30 U Cartridge (TI Inhalation Powder B) Based on Baseline Corrected Insulin AUC0-360 — 3337.2…
Primary Biliary Cirrhosis
Primary: Part 1: Number of Participants With Alkaline Phosphatase (ALP) Response at Week 12 — 0 participants
Depression
Primary: Hamilton Depression Rating Scale Remission Rates — 46.1; 17.6 Percentage of Remitters HDRS17
Tuberculosis · HIV Infections
Primary: CD4+ Lymphocyte Count — -136.0; -107.0 cells/mm^3
Multiple Sclerosis
Primary: Percentages of Patients With Treatment-emergent Adverse Events (TEAEs) or Treatment-emergent Serious Adverse Events (TESAEs) — 100; 100; 88.9; 100 percentage of…
Head and Neck Cancer · Oral Complications of Radiation Therapy · Radiation Toxicity
Primary: Protocol Compliance of Intensity-modulated Radiotherapy Treatment Delivered — 9 participants
Heart Failure · Cardiomyopathy · Ventricular Dysfunction
Primary: Intervention Related Adverse Events — 0; 0 events
Renal Cell Cancer
Primary: Percentage of Participants With Disease Progression or Death — 66.9 percentage of participants
Celiac Disease
Primary: Duodenal Villus Height:Crypt Depth — 2.73; 2.73 Ratio — p=0.693
Rheumatoid Arthritis
Primary: Percentage of Participants Achieving American College of Rheumatology 20 (ACR 20) Response — 10.9; 19.1; 24.4; 39.1 percentage of participants
Acute Myeloid Leukemia · Myelodysplastic Syndromes · Biphenotypic Leukemia
Primary: Disease-Free Survival (DFS) — 78.6 percentage of patients
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities · Adult Acute Myeloid Leukemia With Del(5q) · Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
Primary: Complete Response Rate — 0 percentage of subjects